Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07352514 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Use of PEA and Scutellaria in Synergy With Therapeutic Exercise in Chemotherapy-induced Peripheral Neuropathy (CIPN): a Clinical Trial

StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated January 20, 2026 (before its estimated February 20, 2026 completion). Its status may not reflect the trial's current state.

Record History

  1. Study First Submitted
This study aims to find out if taking specific dietary supplements (PEA and Scutellaria) along with therapeutic exercise can help reduce nerve pain and damage caused by chemotherapy. Many cancer patients experience nerve-related side effects from chemotherapy, which can significantly impact their quality of life. The study will observe patients who use these supplements and exercises to see if they can effectively manage and improve their nerve health and reduce pain.
Trial Details
NCT Number NCT07352514
Lead Sponsor University of Palermo
Conditions
(from sponsor)		 Chemotherapy-induced Peripheral Neuropathy (CIPN), Neuropathic Pain
Related terms Agnosia, Neuralgia
Enrollment 40 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov